The Journal of
Clinical Psychiatry

Volume 73 • 2012 • Supplement 1

Supplement Article

Supplement Article

Introduction: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

J Clin Psychiatry 2012;73(suppl 1):3-4

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP ; David A. Sclar, BPharm, PhD

Supplement Article

The Epidemiology of Depression and the Evolution of Treatment

J Clin Psychiatry 2012;73(suppl 1):5-9

Robert M. A. Hirschfeld, MD

Supplement Article

The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines

J Clin Psychiatry 2012;73(suppl 1):10-16

Michael E. Thase, MD

Supplement Article

Dietary Restrictions and Drug Interactions With Monoamine Oxidase Inhibitors: An Update

J Clin Psychiatry 2012;73(suppl 1):17-24

David A. Flockhart, MD, PhD

Supplement Article

The Transdermal Delivery System of Monoamine Oxidase Inhibitors

J Clin Psychiatry 2012;73(suppl 1):25-30

Chad M. VanDenBerg, PharmD, BCPP

Supplement Article

Issues in Adherence to Treatment With Monoamine Oxidase Inhibitors and the Rate of Treatment Failure

J Clin Psychiatry 2012;73(suppl 1):31-36

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP ; David A. Sclar, BPharm, PhD

Supplement Article

The Use of Monoamine Oxidase Inhibitors in Primary Care

J Clin Psychiatry 2012;73(suppl 1):37-41

Larry Culpepper, MD, MPH

Supplement Article

Discussion: A Fresh Look at Monoamine Oxidase Inhibitors for Depression

J Clin Psychiatry 2012;73(suppl 1):42-45

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP ; David A. Sclar, BPharm, PhD ; Larry Culpepper, MD, MPH ; David A. Flockhart, MD, PhD ; Robert M. A. Hirschfeld, MD ; Michael E. Thase, MD ; Chad M. VanDenBerg, PharmD, BCPP